Nina Gårevik

Nina Gårevik serves as a Lecturer at the Department of Health Sciences, Swedish Red Cross University since 2023. Previously, she taught at Karolinska Institutet (2018-2023) and led their Division of Nursing from 2021-2023. A practicing psychiatric nurse since 1990, she specializes in emergency care and patient safety within psychiatric services, with active professional engagement in the RSMH (Swedish Association for Social and Mental Health) as Deputy Nomination Committee member.

Her academic foundation includes a 2013 PhD from Karolinska Institutet, where her dissertation examined exogenous androgens' quantitative impacts on serum lipids and endocrine functions. Clinical training as a Registered Nurse (RN) underpins her applied research approach.

Research focuses on anabolic androgenic steroid (AAS) abuse in non-athletic populations, particularly young gym-goers, analyzing hormonal disruptions, lipid disorders, and co-abuse patterns. Current projects with Karolinska Institutet and Sweden's Public Health Agency explore youth mental health prerequisites and body image development trajectories. Future work targets subjectively experienced side effects of antipsychotic drugs on cognition and quality of life, emphasizing patient-centered treatment evaluation.

Her publication record shows thematic evolution from physiological AAS impacts (2010-2015) to psychological/behavioral consequences (2016-2020). Key trends include gender-specific abuse patterns, personality disorder linkages, and societal contexts of doping outside sports frameworks. Recent articles highlight aggressive feelings and criminality in AAS users with mental health conditions.

Dr. Gårevik co-authored Sweden's National Care and Treatment Program for AAS users and developed Socialstyrelsen's physician training materials on medications (2015). No student advising or grant leadership is documented in the sources, though collaborative projects suggest participation in larger funded initiatives.

Research operations occur through partnerships with Karolinska Institutet's Department of Laboratory Medicine and the Public Health Agency of Sweden, focusing on interdisciplinary mental health and substance abuse studies targeting youth populations and clinical care optimization.